Skip to main content

News & Announcements


Increased brain activity may compensate for amyloid pathology in older brains


NIH-supported study shows promise for blood test for Alzheimer’s disease


NIH-funded researchers link epigenome changes to Alzheimer’s disease


Physical activity and Alzheimer’s-related hippocampal atrophy


Gene risk factors for age-related brain disorders may affect immune system function


Number of Alzheimer’s deaths found to be underreported


Leadership changes in NIA’s Division of Neuroscience


Longevity gene may boost brain power


Researchers find association between abnormal tau and damaged brain cell DNA


NIH-supported clinical trial finds antidepressant reduces Alzheimer’s agitation


NIH, industry and non-profits join forces to speed validation of disease targets


Rare genetic variants may double risk for Alzheimer’s disease


NIH deposits first batch of genomic data for Alzheimer’s disease


NIH-supported study identifies 11 new Alzheimer’s disease risk genes


NIH funding boosts new Alzheimer’s research on prevention, novel drug targets


Amylin deposits in the brain may link dementia and diabetes


Falls may be sign of future Alzheimer’s disease, cognitive decline


Novel NIH initiative enables testing of existing compound as Alzheimer's treatment


Biomarkers can predict risk for Alzheimer’s several years before symptoms appear


Suppressing protein may stem Alzheimer’s disease process


Gene variant linked to higher risk of Alzheimer’s in African Americans


NIH-supported study finds U.S. dementia care costs as high as $215 billion in 2010


Analysis finds gene variants associated with Alzheimer’s amyloid deposition


NIH-supported Alzheimer’s studies to focus on innovative treatments


NIH-supported international teams identify rare Alzheimer’s disease risk gene variant